Login / Signup

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11.

Enzo BonoraJuan P FriasFrancisco J TinahonesJoanna VanRaleigh E MalikZhuoxin YuReema ModyAngelyn BethelAnita Y M KwanDavid A Cox
Published in: Diabetes, obesity & metabolism (2021)
In patients with T2D, inadequately controlled by metformin, incremental weight loss was observed with dulaglutide 1.5, 3.0 and 4.5 mg doses regardless of baseline BMI or HbA1c. Although absolute weight loss was numerically greater in patients with higher baseline BMI, percentage of weight loss was similar between BMI subgroups.
Keyphrases
  • weight loss
  • weight gain
  • bariatric surgery
  • body mass index
  • roux en y gastric bypass
  • gastric bypass
  • glycemic control
  • obese patients
  • type diabetes
  • skeletal muscle
  • metabolic syndrome
  • body weight